ArticleFrontiers in medicine2026
A clinical study of Simotang oral liquid combined with Shenque acupoint application for abdominal distension after cesarean section.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the preventive and therapeutic effects of Simotang oral liquid combined with Shenque acupoint application on abdominal distension after cesarean section, and assess its safety. Methods: A prospective randomized controlled trial was conducted. Parturients who underwent elective cesarean section in our hospital from June 2024 to June 2025 were enrolled and randomly divided into the intervention group (treated with Simotang oral liquid combined with Shenque acupoint application) and the control group (receiving standard nursing care), with 100 cases in each group. Compare the postoperative recovery indicators of the two groups. Results: The median recovery time of bowel sounds [8 (6, 10) h vs. 12 (10, 14) h], median time to first flatus [20 (17, 26) h vs. 26 (24, 29.5) h], and median time to first defecation [50 (48, 52) h vs. 55 (52, 61) h] in the intervention group were all significantly shorter than those in the control group ( Conclusion: Simotang oral liquid combined with Shenque acupoint application can effectively promote the recovery of gastrointestinal function, alleviate the severity of abdominal distension (though it cannot reduce the overall incidence of distension), and facilitate early lactation after cesarean section, and thus possesses good clinical application value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.